参考文献/References:
[1]LANE N E.Epidemiology,etiology,and diagnosis of osteoporosis[J].Am J Obstet Gynecol,2006,194(2):S3-S11.[2]WANG L,YU W,YIN X,et al.Prevalence of osteoporosis and fracture in China:The China osteoporosis prevalence study[J].JAMA Netw Open,2021,4(8):e2121106.[3]LEBLANC K E,HERBERT L M J,LEBLANC L L.Hip fracture:Diagnosis,treatment,and secondary prevention[J].Am Fam Physician,2014,89(12):945-951.[4]陈志平,赵国阳.OSTA联合下肢血管粥样硬化对中老年患者骨质疏松风险筛查效果[J].中国骨质疏松杂志,2025(4):526-529.[5]SALZMANN S N,ORTIZ MILLER C,CARRINO J A,et al.BMI and gender increase risk of sacral fractures after multilevel instrumented spinal fusion compared with bone mineral density and pelvic parameters[J].Spine J,2019,19(2):238-245.[6]WANG X,ZHANG C,ZHAO G,et al.Obesity and lipid metabolism in the development of osteoporosis (Review)[J].Int J Mol Med,2024,54(1):61.[7]李纪新,邱林杰,任燕,等.肥胖慢性炎症中医药治疗的潜在靶点:巨噬细胞极化[J].中国中药杂志,2023,48(19):5113-5121.[8]LOPES K G,RODRIGUES E L,DA SILVA LOPES M R,et al.Adiposity metabolic consequences for adolescent bone health[J].Nutrients,2022,14(16):3260.[9]ZENG R,LIU F,FANG C,et al.PIV and PILE score at baseline predict clinical outcome of anti-PD-1/PD-L1 inhibitor combined with chemotherapy in extensive-stage small cell lung cancer patients[J].Front Immunol,2021,12:724443.[10]XU H,CAI X,NIU H,et al.Association of PIV value with early mortality in ICU patients with sepsis-associated acute kidney injury from the MIMIC Ⅳ database[J].Sci Rep,2025,15(1):11212.[11]国家卫生健康委员会肥胖症诊疗指南编写委员会.肥胖症诊疗指南(2024年版)[J].中国循环杂志,2025,40(1):6-30.[12]MARDAN M,ZHENG H,XU Q,et al.Comprehensive analysis of pan-immune inflammation and all-cause mortality in rheumatoid arthritis:A database-driven approach,1999-2018[J].Front Immunol,2025,16:1549955.[13]程晓光,徐文坚,吴艳,等.骨质疏松的影像学与骨密度诊断专家共识[J].中国骨质疏松杂志,2020,26(9):1249-1256.[14]中华医学会骨质疏松和骨矿盐疾病分会,章振林.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.[15]COUGHLAN T,DOCKERY F.Osteoporosis and fracture risk in older people[J].Clin Med,2014,14(2):187-191.[16]SCHOTT E M,CHARBONNEAU M R,KIEL D P,et al.A randomized,double-blind,placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food,SBD111,for the clinical dietary management of bone loss in menopausal women[J].Osteoporos Int,2025,36(10):2019-2030.[17]ZHANG J,SUN N,ZHANG W,et al.The impact of uric acid on musculoskeletal diseases:clinical associations and underlying mechanisms[J].Front Endocrinol,2025,16:1515176.[18]XU R,LIAN D,XIE Y,et al.Relationship between serum uric acid levels and osteoporosis[J].Endocr Connect 2023,12(11):e230040.[19]RAMASAMY J,MURUGIAH V,DHANAPALAN A,et al.Diagnostic utility of pan-immune-inflammation value (PIV) in predicting insulin resistance:Results from the national health and nutrition examination survey (NHANES) 2017—2020[J].EJIFCC,2024,35(2):100-110.[20]陈京京,陈盈玲,单浩杰,等.T2DM患者连续血糖监测血糖风险指数与骨代谢标志物、骨密度相关性分析[J].陕西医学杂志,2025,54(6):765-768,774.[21]葛松,牛佩瑶,王燕.不同肥胖类型的骨质疏松症特征改变[J].中华健康管理学杂志,2024,18(2):156-160.[22]姚淑萍,赵成玉.免疫系统与肠道微生物群在骨质疏松中的作用机制[J].中国老年学杂志,2025,45(10):2555-2559.[23]AMEZCUA-GUERRA L M,BRIANZAPADILLA M,MARTNEZ-GARCA M,et al.Establishment of high-altitude reference values for the pan-immune-inflammation value in healthy adults living in Mexico city[J].Arch Med Res,2026,57(1):103281.[24]陈宏丹,梁荣珍,林德文,等.老年2型糖尿病患者血清Hb、 NLR与BMD、骨代谢及骨质疏松的相关性[J].中国老年学杂志,2023,43(5):1043-1045.[25]沈灵杰,秦超,刘合飞.自体富血小板血浆通过Notch1调节骨质疏松大鼠骨折愈合[J].中国骨质疏松杂志,2024,30(2):181-186,209.
相似文献/References:
[1]李 洺,赵 宇△,马 丁,等.女性绝经后骨质疏松症患者血清铁蛋白、同源拮抗物表达水平及临床意义*[J].陕西医学杂志,2020,49(10):1266.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.017]
LI Ming,ZHAO Yu,MA Ding,et al.Expression and clinical significance of serum ferritin and B-cell lymphoma factor 2 homologous antagonist in postmenopausal women with osteoporosis[J].,2020,49(6):1266.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.017]
[2]昌 震,李大同,杨小彬,等.奇壬醇对骨质疏松症的治疗作用及机制研究进展[J].陕西医学杂志,2022,51(9):1167.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.029]
CHANG Zhen,LI Datong,YANG Xiaobin,et al.Research progress on therapeutic effect and mechanism of Kirenol on osteoporosis[J].,2022,51(6):1167.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.029]
[3]张亮亮,赵程锦,周煜虎,等.积雪草酸对大鼠绝经后骨质疏松症的治疗作用及机制研究[J].陕西医学杂志,2023,52(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.002]
ZHANG Liangliang,ZHAO Chengjin,ZHOU Yuhu,et al.Therapeutic effect and mechanism of asiatic acid on postmenopausal osteoporosis in rats[J].,2023,52(6):1624.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.002]
[4]彭 赛,卢丛兰,孙中洋.人工智能在骨质疏松症诊疗中的应用进展[J].陕西医学杂志,2024,(3):425.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.030]
PENG Sai,LU Conglan,SUN Zhongyang.Advances in application of artificial intelligence in diagnosis and treatment of osteoporosis[J].,2024,(6):425.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.030]
[5]解静,汪永新.MSX1基因调控Wnt/β-catenin通路刺激成骨分化和骨形成机制实验研究[J].陕西医学杂志,2025,54(6):754.[doi:DOI:10.3969/j.issn.1000-7377.2025.06.006]
XIE Jing,WANG Yongxin.Mechanism of MSX1 regulating Wnt/β-catenin pathway to stimulate osteogenic differentiation and bone formation[J].,2025,54(6):754.[doi:DOI:10.3969/j.issn.1000-7377.2025.06.006]
[6]周浩然,郑志杰,李瑞忠.血清PTX3、ANXA2、IL-33在老年骨质疏松症患者中的表达变化及其预测并发骨折价值[J].陕西医学杂志,2025,54(6):819.[doi:DOI:10.3969/j.issn.1000-7377.2025.06.019]
ZHOU Haoran,ZHENG Zhijie,LI Ruizhong.Expression of serum PTX3,ANXA2 and IL-33 in elderly patients with osteoporosis and their predictive value for fracture[J].,2025,54(6):819.[doi:DOI:10.3969/j.issn.1000-7377.2025.06.019]